Page last updated: 2024-08-17

apomorphine and abt724

apomorphine has been researched along with abt724 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatia, P; Brioni, JD; Chang, R; Cowart, M; Daanen, JF; Donnelly-Roberts, DL; Hollingsworth, PR; Hsieh, GC; Kolasa, T; Latshaw, SP; Lynch, JJ; Martino, BR; Miller, LN; Moreland, RB; Nakane, M; Namovic, MT; Nelson, SL; Patel, M; Rohde, J; Stewart, AO; Sullivan, JP; Terranova, MA; Uchic, ME	1
Brioni, JD; Chang, R; Cowart, MD; Darbyshire, JF; Donnelly-Roberts, DL; El-Kouhen, OF; Gintant, G; Hakeem, AA; Hollingsworth, PR; Hsieh, GC; Kolasa, T; Marsh, KC; Martin, R; Martino, BR; Matulenko, MA; Miller, LN; Moreland, RB; Mortell, K; Nakane, M; Namovic, MT; Nelson, SL; Patel, MV; Rohde, JJ; Stewart, AO; Sullivan, JP; Terranova, MA; Uchic, ME; Wetter, JM	1

Other Studies

2 other study(ies) available for apomorphine and abt724

Article	Year
Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. Journal of medicinal chemistry, 2004, Jul-15, Volume: 47, Issue:15 Topics: Animals; Benzimidazoles; Cell Line; Erectile Dysfunction; Ferrets; Humans; Male; Penile Erection; Piperazines; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship; Vomiting	2004
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. Journal of medicinal chemistry, 2006, Dec-14, Volume: 49, Issue:25 Topics: Action Potentials; Administration, Oral; Animals; Benzamides; Biological Availability; Cell Line; Cyclic N-Oxides; Dogs; Erectile Dysfunction; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Haplorhini; Humans; In Vitro Techniques; Male; Patch-Clamp Techniques; Purkinje Fibers; Rats; Receptors, Dopamine D4; Structure-Activity Relationship	2006

Article

Year

Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.

Journal of medicinal chemistry, 2004, Jul-15, Volume: 47, Issue:15

Topics: Animals; Benzimidazoles; Cell Line; Erectile Dysfunction; Ferrets; Humans; Male; Penile Erection; Piperazines; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship; Vomiting

2004

Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.

Journal of medicinal chemistry, 2006, Dec-14, Volume: 49, Issue:25

Topics: Action Potentials; Administration, Oral; Animals; Benzamides; Biological Availability; Cell Line; Cyclic N-Oxides; Dogs; Erectile Dysfunction; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Haplorhini; Humans; In Vitro Techniques; Male; Patch-Clamp Techniques; Purkinje Fibers; Rats; Receptors, Dopamine D4; Structure-Activity Relationship

2006